New Complaint Filed in N.D.Tex. Challenges Mifepristone Regulation
The States of Missouri, Kansas, and Idaho have sued the FDA challenging the regulatory framework for Mifepristone. The suit is filed in the United States District Court for the Northern District of Texas Amarillo Division.
Publication Details
- Journal
- eYLS (Yale Law School)
- Published
- 2024-10-21
- Primary Topic
- Nuclear Structure and Function
- Type
- article
- Field-Weighted Citation Impact
- 0.00